The effect of RGD peptides on osseointegration of hydroxyapatite biomaterials

被引:126
作者
Hennessy, Kristin M. [1 ]
Clem, Will C. [2 ]
Phipps, Matthew C. [3 ]
Sawyer, Amber A. [4 ]
Shaikh, Faheem M. [1 ]
Bellis, Susan L. [1 ,2 ]
机构
[1] Univ Alabama, Dept Physiol & Biophys, Birmingham, AL 35294 USA
[2] Univ Alabama, Dept Biomed Engn, Birmingham, AL 35294 USA
[3] Univ Notre Dame, Dept Phys, Notre Dame, IN 46556 USA
[4] ASTAR, Inst Mol & Cell Biol, Stem Cells & Tissue Repair Grp, Singapore 138673, Singapore
关键词
bioadsorption; bone tissue engineering; cell adhesion; hydroxyapatite; osseointegration; RGD peptide;
D O I
10.1016/j.biomaterials.2008.04.014
中图分类号
R318 [生物医学工程];
学科分类号
0831 [生物医学工程];
摘要
Given that hydroxyrapatite (HA) biomaterials are highly efficient at adsorbing proadhesive proteins, we questioned whether functionalizing HA with RGD peptides would have any benefit. In this study, we implanted uncoated or RGD-coated HA disks into rat tibiae for 30 min to allow endogenous protein adsorption, and then evaluated mesenchymal stem cell (MSC) interactions with the retrieved disks. These experiments revealed that RGD, when presented in combination with adsorbed tibial proteins (including fibronectin, vitronectin and fibrinogen), has a markedly detrimental effect on MSC adhesion and survival. Moreover, analyses of HA disks implanted for 5 days showed that RGD significantly inhibits total bone formation as well as the amount of new bone directly contacting the implant perimeter. Thus, RGD, which is widely believed to promote cell/biomaterial interactions, has a negative effect on HA implant performance. Collectively these results suggest that, for biomaterials that are highly interactive with the tissue microenvironment, the ultimate effects of RGD will depend upon how signaling from this peptide integrates with endogenous processes such as protein adsorption. (c) 2008 Elsevier Ltd. All rights reserved.
引用
收藏
页码:3075 / 3083
页数:9
相关论文
共 47 条
[1]
Akiyama S K, 1996, Hum Cell, V9, P181
[2]
Modulating bone cells response onto starch-based biomaterials by surface plasma treatment and protein adsorption [J].
Alves, Catarina M. ;
Yang, Y. ;
Carnes, D. L. ;
Ong, J. L. ;
Sylvia, V. L. ;
Dean, D. D. ;
Agrawal, C. M. ;
Reis, R. L. .
BIOMATERIALS, 2007, 28 (02) :307-315
[3]
CELLULAR AND MOLECULAR BIOLOGICAL EVENTS AT THE IMPLANT INTERFACE [J].
BAGAMBISA, FB ;
KAPPERT, HF ;
SCHILLI, W .
JOURNAL OF CRANIO-MAXILLOFACIAL SURGERY, 1994, 22 (01) :12-17
[4]
Using hydroxyapatite nanoparticles and decreased crystallinity to promote osteoblast adhesion similar to functionalizing with RGD [J].
Balasundaram, G ;
Sato, M ;
Webster, TJ .
BIOMATERIALS, 2006, 27 (14) :2798-2805
[5]
Peri-implant bone formation and implant integration strength of peptide-modified p(AAm-co-EG/AAc) interpenetrating polymer network-coated titanium implants [J].
Barber, Thomas A. ;
Ho, James E. ;
De Ranieri, Aladino ;
Virdi, Amarjit S. ;
Sumner, Dale R. ;
Healy, Kevin E. .
JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A, 2007, 80A (02) :306-320
[6]
Carvalho RS, 1998, J CELL BIOCHEM, V70, P376, DOI 10.1002/(SICI)1097-4644(19980901)70:3<376::AID-JCB11>3.0.CO
[7]
2-J
[8]
Blood coagulation [J].
Dahlback, B .
LANCET, 2000, 355 (9215) :1627-1632
[9]
Deligianni D, 2005, J SPINAL DISORD TECH, V18, P257
[10]
In vivo study of the effect of RGD treatment on bone ongrowth on press-fit titanium alloy implants [J].
Elmengaard, B ;
Bechtold, JE ;
Soballe, K .
BIOMATERIALS, 2005, 26 (17) :3521-3526